Nearly every major class of antidepressant has been linked to some form of fluid retention, but the risk is not spread evenly. Mirtazapine, trazodone, and escitalopram top the list for peripheral edema, the visible puffiness that shows up in ankles, feet, and lower legs. SSRIs and SNRIs as a group can also cause a less obvious form of fluid retention by disrupting how your body handles sodium and water. The difference between a drug that rarely causes problems and one that carries a meaningful risk matters, and the answer depends on both the specific medication and who is taking it.
The Antidepressants Most Commonly Linked to Swelling
A large hospital-based study that tracked adverse drug reactions in over 240,000 patients treated with psychotropic medications found that mirtazapine was the single most-implicated antidepressant for edema, accounting for about one in five of all edema cases across every psychotropic drug class. Its incidence among antidepressants was the highest at roughly 0.8 per thousand patients treated.1PubMed Central. Edema related to treatment with psychotropic drugs A separate systematic review of published case reports came to a similar conclusion, finding that trazodone, mirtazapine, and escitalopram were the three antidepressants most frequently implicated in peripheral edema.2PubMed. Peripheral edema associated with antidepressant use: Systematic review of case reports
These are not all from the same drug family. Mirtazapine is a noradrenergic and specific serotonergic antidepressant (sometimes called a NaSSA), trazodone is a serotonin modulator often prescribed at low doses for sleep, and escitalopram is a widely used SSRI. What they share, as we’ll see below, is a common pharmacological trait that encourages blood vessels to relax and leak fluid into surrounding tissue.
That said, overall edema from antidepressants is uncommon in absolute terms. The same large study found that edema occurred in roughly 0.39 per thousand patients treated with antidepressants, meaning the vast majority of people on these medications never experience noticeable swelling.1PubMed Central. Edema related to treatment with psychotropic drugs But “uncommon” does not mean unimportant if you are the person whose shoes suddenly feel tight two weeks into a new prescription.
Why Certain Antidepressants Cause Edema
The systematic review of case reports pointed to two receptor-level mechanisms as the most common culprits behind antidepressant-related swelling: blockade of alpha-1 adrenergic receptors and blockade of serotonin 5HT2A receptors.2PubMed. Peripheral edema associated with antidepressant use: Systematic review of case reports Both of these receptor types normally help maintain the tone of small blood vessels. When a drug blocks them, the vessels dilate. That widening increases the pressure inside tiny capillaries, which pushes fluid out of the bloodstream and into the tissue around the ankles, feet, and lower legs, where gravity keeps it pooled.
This explains why mirtazapine and trazodone show up so often in edema reports. Both have strong alpha-1 blocking activity and meaningful 5HT2A antagonism, a pharmacological profile that essentially double-dips on vasodilation. Escitalopram is primarily an SSRI, but it too has enough serotonin-receptor activity downstream to contribute to this effect in susceptible individuals. One published case described a 58-year-old woman who developed swelling in both lower legs after starting a low dose of escitalopram, which resolved when the drug was stopped.3PubMed Central. Case report: Escitalopram-associated lower limb edema
Mirtazapine-related edema tends to appear quickly. A case report documented peripheral edema developing within three days of starting 15 mg daily in a palliative-care patient, with the swelling resolving completely once the drug was discontinued.4PubMed. Peripheral Edema as an Adverse Drug Reaction to Mirtazapine in an Oral Cavity Cancer Patient Receiving Palliative Care at Tertiary Care Centre: A Case Report That quick onset and quick resolution is typical of a vasodilation-driven mechanism, and it is a useful clinical clue when trying to figure out whether a new medication is causing the problem.
A Different Kind of Fluid Retention From SSRIs and SNRIs
Peripheral edema, the kind you can see and press a thumb into, is only one way antidepressants affect fluid balance. SSRIs and SNRIs can cause a second, less visible form of fluid retention by interfering with how your kidneys handle water. The condition is called syndrome of inappropriate antidiuretic hormone, or SIADH, and it works through a different pathway than the vasodilation mechanism described above.
Under normal conditions, antidiuretic hormone (ADH) tells the kidneys to hold onto water when your body needs it and backs off when you’re well hydrated. SSRIs can increase the release of ADH beyond what the body actually needs, which causes the kidneys to retain too much water.5PubMed Central. Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Induced by Long-Term Use of Citalopram and Short-Term Use of Naproxen The excess water dilutes your blood sodium, a condition called hyponatremia. Mild hyponatremia might show up as subtle bloating, fatigue, or nausea. Severe cases can cause confusion, seizures, and even be life-threatening.
This is worth understanding because it means that someone on an SSRI might not have visible ankle swelling but could still be retaining excess water in a way that affects how they feel. The weight gain people sometimes notice in the first weeks on an SSRI, before any appetite changes have had time to add body fat, can partly reflect this water retention.
Which SSRIs and SNRIs Carry Higher and Lower Hyponatremia Risk
Not all drugs in these classes are equally prone to disrupting sodium balance. A systematic review and meta-analysis that pooled data across multiple studies found that among SSRIs, fluoxetine carried the highest risk of hyponatremia, while sertraline was associated with a lower risk. Among SNRIs, venlafaxine came out with the highest risk, and duloxetine showed a comparatively lower risk.6PubMed Central. The risk of hyponatremia induced by SSRIs and SNRIs antidepressants: a systematic review and meta-analysis
A separate study that combined different lines of evidence to compare individual drugs found that fluvoxamine, among the SSRIs, and milnacipran, among the SNRIs, stood out as options that did not appear to lower serum sodium at all.7PubMed Central. Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies That makes these two potentially useful alternatives for patients who have had sodium problems on other antidepressants, though the overall evidence base for milnacipran in this context is smaller.
The picture that emerges is a rough spectrum within the SSRI/SNRI family. Fluoxetine and venlafaxine sit at the higher-risk end for sodium disruption, sertraline and duloxetine somewhere in the middle-to-lower range, and fluvoxamine and milnacipran at the lower end. These rankings matter most for people who already have risk factors for low sodium, which we’ll turn to next.
Who Gets Hit Hardest
Both forms of antidepressant-related fluid retention, peripheral edema and sodium-dilution hyponatremia, hit some groups harder than others. The systematic review of edema case reports noted that older age and female sex were more commonly associated with the reaction.2PubMed. Peripheral edema associated with antidepressant use: Systematic review of case reports A large pharmacovigilance study spanning 24 years confirmed this sex difference in striking terms: women had about six times the incidence of antidepressant-related edema compared to men, and nearly three times the incidence of hyponatremia.8PubMed Central. A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs
For the hyponatremia pathway specifically, additional risk factors include low body weight, already-low baseline sodium levels, and concurrent use of diuretics.9PubMed Central. Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Induced by Long-Term Use of Citalopram and Short-Term Use of Naproxen – Section: Discussion If you’re an older woman with a smaller frame who is already taking a blood pressure pill that makes you urinate more, your risk of developing a clinically meaningful sodium drop on an SSRI is considerably higher than the population average.
The age factor deserves emphasis. Older adults have less ability to compensate for shifts in fluid balance because kidney function naturally declines, thirst signals become blunted, and overall body water decreases with age. A sodium drop that a 30-year-old would shrug off can send a 75-year-old to the emergency room with confusion or a fall.
The Interaction Problem With Other Medications
One of the more dangerous aspects of antidepressant-related fluid retention is how it interacts with other common drugs. Thiazide diuretics, a widely prescribed class of blood pressure medications, promote sodium and water loss through the kidneys. When combined with an SSRI that is simultaneously pushing the kidneys to retain excess water, the two effects can clash in a way that drives sodium to dangerously low levels. A report of two cases of severe hyponatremia in patients taking both a thiazide diuretic and an SSRI highlighted what the authors described as a synergistic effect on the kidneys’ ability to clear free water, and recommended careful monitoring whenever both drugs are prescribed together, especially in elderly women.10The American Journal of the Medical Sciences. Severe Hyponatremia Associated with the Combined Use of Thiazide Diuretics and Selective Serotonin Reuptake Inhibitors
Non-steroidal anti-inflammatory drugs (NSAIDs) are another concern. One published case described SIADH developing in a patient on long-term citalopram after a short course of naproxen was added, suggesting that NSAIDs can tip a borderline situation into clinical hyponatremia.5PubMed Central. Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Induced by Long-Term Use of Citalopram and Short-Term Use of Naproxen NSAIDs reduce blood flow to the kidneys and impair their ability to excrete water, which compounds whatever ADH-related water retention the SSRI is already causing. Since many people reach for over-the-counter ibuprofen or naproxen without a second thought, this is an interaction that can sneak up on people who wouldn’t consider themselves at risk.
The practical implication is straightforward: if you’re on an SSRI or SNRI and take diuretics or regular NSAIDs, your prescriber should be aware of the combination and may want to check your sodium periodically, especially in the first few weeks after starting or changing doses.
How SSRIs Affect Hormones That Regulate Fluid
Beyond the ADH pathway, SSRIs may also influence fluid balance through the aldosterone system, though this effect is subtler and less clinically dramatic. Aldosterone is a hormone that tells the kidneys to hold onto sodium and, with it, water. A study of depressed men treated with either sertraline or escitalopram found that both drugs were associated with rising aldosterone levels over six weeks of treatment.11The Journal of Clinical Endocrinology & Metabolism. Effects of Two Selective Serotonin Reuptake Inhibitor Antidepressants, Sertraline and Escitalopram, on Aldosterone/Renin Ratio in Normotensive Depressed Male Patients
Interestingly, the body appeared to compensate: renin activity also rose, meaning the overall aldosterone-to-renin ratio actually fell over time. The clinical significance of this shift is unclear, and it did not cause overt edema in the study participants. But it does suggest that SSRIs interact with the hormonal machinery of fluid balance in ways that go beyond simple ADH release, and it might help explain why some people notice mild puffiness or a few extra pounds of water weight early in SSRI treatment that stabilizes over time as the body adjusts.
Tricyclic Antidepressants and Older Drug Classes
Tricyclic antidepressants (TCAs), the older generation of drugs like amitriptyline, nortriptyline, and imipramine, are strong alpha-1 blockers. Given that alpha-1 receptor blockade is one of the two main mechanisms behind antidepressant-related edema, you might expect TCAs to be heavy offenders. They can cause edema, and case reports exist, but they do not dominate the literature to the same degree as mirtazapine or trazodone. This is likely because TCAs are prescribed far less frequently today than they were decades ago, so they simply generate fewer adverse-event reports in modern datasets.
Monoamine oxidase inhibitors (MAOIs) like phenelzine and tranylcypromine are prescribed even less frequently. The systematic review found that almost all major classes of antidepressants were associated with edema, and MAOIs are not excluded from that statement, but the evidence base is thin simply because so few patients are on these drugs.2PubMed. Peripheral edema associated with antidepressant use: Systematic review of case reports If you are one of the relatively small number of people taking a TCA or MAOI, the theoretical risk for edema exists, but the practical reporting is sparse enough that rates are hard to pin down.
What to Do If You Notice Fluid Retention
If you develop new swelling in your feet, ankles, or lower legs after starting or changing an antidepressant, the first step is to confirm the medication is the likely cause rather than assuming. Edema has many potential triggers, including heart, liver, or kidney problems, so a prescriber will usually want to rule those out, especially if the swelling is severe or one-sided (which can suggest a blood clot rather than a drug side effect).
For mild cases clearly linked to a medication change, the swelling often resolves once the drug is stopped or the dose is lowered. In the case reports, resolution after discontinuation was a consistent pattern. The question then becomes whether you and your prescriber can find an antidepressant that treats your depression without causing the same problem. Given that the vasodilation mechanism is driven primarily by alpha-1 and 5HT2A receptor blockade, switching to a drug with less activity at those receptors is a logical strategy. An SSRI with lower alpha-1 effects, or a drug like bupropion that works through an entirely different mechanism, might be a reasonable alternative depending on your clinical situation.
For fluid retention driven by the hyponatremia pathway, a sodium check via a simple blood test can clarify what is happening. If sodium is low, the prescriber might switch to an SSRI with a lower hyponatremia risk (like sertraline or fluvoxamine) or to a non-serotonergic antidepressant. If the antidepressant is otherwise working well and the sodium drop is mild, careful monitoring with periodic lab checks is sometimes enough.
Elevating your legs, reducing salt intake, and staying gently active can help manage mild edema while you and your prescriber sort out the medication question, but these measures treat the symptom rather than the cause. The underlying issue is that the drug is changing how your blood vessels or kidneys behave, and the definitive fix is usually adjusting the drug.
Why This Side Effect Gets Overlooked
Fluid retention from antidepressants tends to fly under the radar for a few reasons. The overall incidence is low enough that it does not appear prominently in prescribing information beyond a line item buried in a long side-effect list. Many patients attribute the puffiness or weight gain to the depression itself, to dietary changes, or to normal aging. And the hyponatremia form is especially insidious because it can produce vague, nonspecific symptoms like fatigue, nausea, or difficulty concentrating, which overlap with the very condition the antidepressant is being used to treat. A patient who starts an SSRI and feels more foggy or tired a few weeks later might assume the drug isn’t working, when in reality the drug is doing something unexpected to their sodium balance.
Women face a particular version of this problem. With roughly six times the incidence of edema and nearly three times the incidence of hyponatremia compared to men, women are disproportionately affected and also disproportionately likely to have their complaints attributed to hormonal fluctuations rather than to the medication.8PubMed Central. A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs If you notice new swelling or unexplained puffiness after starting an antidepressant, bringing it up with your prescriber is worth the conversation, especially if you fall into a higher-risk group. The side effect is real, it is treatable, and in most cases it does not mean you have to stop treating your depression — just that you may need a different drug to do it.